Literature DB >> 24461248

Two-stage revision for prosthetic joint infection: outcome and role of reimplantation microbiology in 107 cases.

Ari-Pekka Puhto1, Teija M Puhto2, Tuukka T Niinimäki1, Juhana I Leppilahti1, Hannu P T Syrjälä2.   

Abstract

Two-stage revision is widely used for the treatment of prosthetic joint infections. However, the duration of antibiotic treatment between stages and role of reimplantation microbiology are controversial. The purpose of this study was to evaluate the outcome and influence of the reimplantation microbiology of two-staged revisions with 6 weeks of antibiotic treatment. We retrospectively reviewed 107 patients treated with two-stage revision between 2001 and 2009. The overall treatment success rate was 94.4%. The reimplantation cultures were positive in 5/97 (5.2%) cases, and only one of them failed. Therefore, we achieved excellent results with a 6-week course of antibiotics between stages in two-stage revision. Positive reimplantation cultures do not seem to be associated with worse outcomes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibiotic treatment; arthroplasty; prosthetic joint infection; reimplantation microbiology; two-stage revision

Mesh:

Substances:

Year:  2013        PMID: 24461248     DOI: 10.1016/j.arth.2013.12.027

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  14 in total

1.  Two-Stage Total Knee Arthroplasty for Prosthetic Joint Infection.

Authors:  Min Seok Cha; Se Hyun Cho; Dong Hee Kim; Hong Kwon Yoon; Ho Seung Cho; Dong Yeong Lee; Sang Hyuk Lee; Sun Chul Hwang
Journal:  Knee Surg Relat Res       Date:  2015-06-01

2.  Late Reinfection May Recur More Than 5 Years After Reimplantation of THA and TKA: Analysis of Pathogen Factors.

Authors:  Kevin L Garvin; Ryan E Miller; Todd M Gilbert; Anthony M White; Elizabeth R Lyden
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

3.  Synovial Cell Count Before Reimplantation Can Predict the Outcome of Patients with Periprosthetic Knee Infections Undergoing Two-stage Exchange.

Authors:  Tiziana Ascione; Giovanni Balato; Massimo Mariconda; Francesco Smeraglia; Andrea Baldini; Cristiano De Franco; Giuseppe Pandolfo; Roberta Siciliano; Pasquale Pagliano
Journal:  Clin Orthop Relat Res       Date:  2021-09-01       Impact factor: 4.755

4.  Efficacy of Single-stage Revision with Aggressive Debridement Using Intra-articular Antibiotics in the Treatment of Infected Joint Prosthesis.

Authors:  Suresh J Antony; Richard S Westbrook; John S Jackson; Jacob S Heydemann; Jenny L Nelson
Journal:  Infect Dis (Auckl)       Date:  2015-07-30

Review 5.  Two-stage Revision for Periprosthetic Hip and Knee Joint Infections.

Authors:  Sunil Gurpur Kini; Ayman Gabr; Rishi Das; Mohamed Sukeik; Fares Sami Haddad
Journal:  Open Orthop J       Date:  2016-11-30

6.  Outcome of Irrigation and Debridement after Failed Two-Stage Reimplantation for Periprosthetic Joint Infection.

Authors:  M Faschingbauer; F Boettner; R Bieger; C Weiner; H Reichel; T Kappe
Journal:  Biomed Res Int       Date:  2018-10-11       Impact factor: 3.411

7.  [Research progress of two-stage revision for periprosthetic joint infection after hip and knee arthroplasties].

Authors:  Xiangxuan Wang; Wenming Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-12-15

8.  2-stage revision of 120 deep infected hip and knee prostheses using gentamicin-PMMA beads.

Authors:  Daniël M C Janssen; Jan A P Geurts; Liesbeth M C Jütten; Geert H I M Walenkamp
Journal:  Acta Orthop       Date:  2016-01-28       Impact factor: 3.717

9.  Ertapenem Articulating Spacer for the Treatment of Polymicrobial Total Knee Arthroplasty Infection.

Authors:  Dragan Radoicic; Milomir Milanovic; Jugoslav Marinkovic; Danica Radoicic
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-30       Impact factor: 2.471

10.  Immunomimetic Designer Cells Protect Mice from MRSA Infection.

Authors:  Ying Liu; Peng Bai; Anne-Kathrin Woischnig; Ghislaine Charpin-El Hamri; Haifeng Ye; Marc Folcher; Mingqi Xie; Nina Khanna; Martin Fussenegger
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.